ARCHIVES

NCI To Require Reports On Adverse Drug Reactions From Trials

This article is from The Cancer Letter archive.

Vol. 20 No. 23 | June 10, 1994

Download PDF Visit The Full Archive

Related Articles

FDA Policy: silicone Breast Implant Restrictions Stand, FDA Tells Petitioners

November 7, 1997

In Brief: NCI Funded To Dec. 15, No Senate Figure Yet; Speedup Urged On Interferon Manufacturing, Testing

October 10, 1980

John Ultmann, Chicago’s Outspoken Director, Heads In Retirement

August 30, 1991

DCBD Concepts Approved

November 8, 1985

ACS Goal To Raise Percentage Of Women Who Get Mammograms

July 31, 1992

Studies Are Demonstrating Effectiveness of Drug Combinations As Adjuvant Therapy; NCI Will Support New Clinical Trials

April 5, 1974